Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB26FUJLZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,849
Award facts
- Contract value 100% obligated
- $6,848.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $6,848.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, awarded on October 23, 2025, with an ultimate completion date of November 14, 2025, carries no set-aside designation, indicating the contractor won the award through open competition. The contract was executed without subcontractor involvement, with DMS Pharmaceutical Group providing direct delivery to the Park Ridge, Illinois location.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense healthcare operations. The underlying IDC, valued at $499,999,999 and awarded on November 13, 2025, extends through December 31, 2036, and authorizes the Defense Logistics Agency to issue delivery orders for branded and generic pharmaceuticals, biologics, and medical consumables to support military healthcare facilities globally. DMS Pharmaceutical Group's established performance on numerous prior delivery orders across diverse therapeutic categories demonstrates its capability as a critical supplier within the federal military pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB26FUJLZ?
SPE2DB26FUJLZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FUJLZ worth?
The government has obligated $6,849 on SPE2DB26FUJLZ.
Is contract SPE2DB26FUJLZ an order under another contract?
Yes. SPE2DB26FUJLZ is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB26FUJLZ competed?
The extent of competition for SPE2DB26FUJLZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award